Related by context. All words. (Click for frequent words.) 65 atherosclerotic disease 63 atherosclerotic cardiovascular disease 62 myocardial ischemia 62 de ath 61 coronary artery disease 61 left ventricular hypertrophy 61 occlusive disease 61 arterial calcification 61 cardiac dysfunction 61 Coronary artery calcification 60 vascular inflammation 60 systolic dysfunction 60 thromboembolic 60 carotid stenosis 60 cardiovascular hospitalization 60 thrombotic events 60 atherosclerosis 60 nonalcoholic steatohepatitis 60 carotid atherosclerosis 60 reinfarction 59 preserved ejection fraction 59 atherosclerotic coronary 59 rhythm disturbances 59 thrombotic complications 59 coronary artery atherosclerosis 59 abdominal adiposity 59 renal fibrosis 59 noncardiac 59 postoperative delirium 59 autonomic dysfunction 59 hepatic steatosis 59 cardiovascular morbidity 59 hypoperfusion 59 atherogenesis 59 myocardial infarctions 59 subclinical atherosclerosis 59 intracranial bleeding 59 metabolic acidosis 59 aortic atherosclerosis 59 CVD mortality 59 cardiac hypertrophy 59 atherothrombotic disease 58 left ventricular dysfunction 58 renal dysfunction 58 atherosclerotic lesions 58 elevated triglycerides 58 intracerebral haemorrhage 58 MGUS 58 macrovascular events 58 thromboembolism 58 metachronous 58 prostate cancer CaP 58 node metastases 58 arrhythmogenic 58 LVNC 58 postoperative pulmonary 58 cerebrovascular diseases 58 carotid IMT 58 LV dysfunction 58 thromboembolic events 58 embolic stroke 58 coronary blockages 58 systolic hypertension 58 CP CPPS 58 Erythropoietic therapies may 58 aminotransferase ALT 58 variceal bleeding 58 β blockers 58 colorectal adenoma 58 atherosclerotic 58 cardiovascular hospitalizations 58 cirrhosis liver failure 58 cholangiocarcinoma 58 platelet activation 58 fibrosis scarring 58 adrenalectomy 58 elevated triglyceride levels 58 coronary artery calcification 57 unstable angina pectoris 57 microbleeds 57 potentially modifiable 57 Hemorrhagic stroke 57 gallstone disease 57 rebleeding 57 myocardial infarction 57 recurrent myocardial infarction 57 nephrotoxicity 57 nonischemic 57 airway hyperresponsiveness 57 arterial stiffness 57 myocardial ischaemia 57 hyperhomocysteinemia 57 perioperative complications 57 symptomatic VTE 57 carotid plaque 57 ventricular remodeling 57 myocardial reperfusion 57 Myocardial infarction 57 gastric carcinoma 57 obstructive coronary artery 57 acute aortic dissection 57 prothrombotic 57 hypercoagulable 57 ventricular arrhythmia 57 hyperglycaemia 57 myocardial infarction stroke 57 NAFLD 57 SSc 57 Lp PLA 2 57 microvascular disease 57 Left ventricular hypertrophy 57 atherothrombosis 57 aortic stiffness 57 albuminuria 57 microalbuminuria 57 atherosclerotic plaque 57 nonmelanoma skin cancers 57 fibrosis 57 postoperative atrial fibrillation 57 microvascular complications 57 hemorrhagic complications 57 extrapyramidal symptoms 57 lung fibrosis 57 coronary stenosis 57 intracranial hypertension 57 myocardial fibrosis 57 diabetic kidney 56 arterial stiffening 56 cardiovascular mortality 56 cerebral microbleeds 56 metabolic abnormalities 56 glomerular filtration 56 carotid artery blockage 56 distensibility 56 clinically detectable 56 perioperative mortality 56 renal insufficiency 56 PAOD 56 aortic valve stenosis 56 artery stenosis 56 cardiac insufficiency 56 hypertensive cardiovascular disease 56 torsade de pointes 56 postoperative AF 56 acute myocardial infarction MI 56 Statin therapy 56 noncardiovascular 56 atherosclerotic vascular disease 56 vascular dysfunction 56 ischemic cardiomyopathy 56 thromboembolic complications 56 Genetic variants 56 SIADH 56 lung metastasis 56 coronary disease 56 ADPKD 56 valvular disease 56 hepatic cirrhosis 56 coronary artery calcium 56 Lp PLA2 56 cerebral vasospasm 56 thyroid dysfunction 56 RIP1 56 arteriosclerotic cardiovascular disease 56 Cholangiocarcinoma 56 hypoxemia 56 symptomatic intracranial 56 Subgroup analysis 56 Insulin resistance 56 decompensated heart failure 56 bronchial pneumonia quadriplegia spinal 56 ventricular tachyarrhythmia 56 atheroma 56 tumoral 56 cardiovascular disease hypertension 56 Non Alcoholic Fatty 56 Aortic stenosis 56 vascular permeability 56 dyslipidaemia 56 endometrial carcinoma 56 recurrent DVT 56 lipid abnormalities 56 acute coronary syndromes 56 onset diabetes mellitus 56 leukotriene pathway 56 nonalcoholic steatohepatitis NASH 56 cardiovascular disease 56 ischemic complications 56 esophageal cancers 56 atherothrombotic 56 venous thrombosis 56 endotoxemia 56 Secondhand smoke exposure 56 carotid intima media 56 chronic periodontitis 56 subclinical hypothyroidism 56 acute humoral rejection 56 lung edema 56 postmenopausal hormone 56 ventricular dysfunction 56 infarct size 56 endometrial hyperplasia 56 arterial thickening 56 cardiac biomarkers 56 silent ischemia 56 upper gastrointestinal bleeding 56 portal vein thrombosis 56 hepatocellular 55 pulmonary dysfunction 55 atherosclerosis narrowing 55 infarcts 55 thickness IMT 55 Diabetic nephropathy 55 liver cirrhosis 55 infarctions 55 VEGF induced 55 hyperinsulinemia 55 coronary calcification 55 endothelial activation 55 salmeterol HFA MDI 55 abnormal lipid 55 lymphocyte counts 55 cartilage degeneration 55 persistent pulmonary hypertension 55 colorectal adenomas 55 subclinical hyperthyroidism 55 platelet reactivity 55 renal cell carcinomas 55 neurologic dysfunction 55 PlGF 55 periprocedural MI 55 aneurysmal subarachnoid hemorrhage 55 spontaneous bacterial peritonitis 55 cryptogenic stroke 55 neuropathological 55 cardiac fibrosis 55 oesophageal adenocarcinoma 55 nondiabetic patients 55 cerebral infarction 55 intimal hyperplasia 55 microvascular dysfunction 55 cerebrovascular disease 55 predisposing factor 55 vasculopathy 55 thrombosis 55 Thrombocytopenia 55 heparin induced thrombocytopenia 55 vascular disease 55 neointimal hyperplasia 55 disc degeneration 55 leiomyomas 55 hypervascular tumors 55 impaired glucose metabolism 55 ventricular arrhythmias 55 Helicobacter pylori infection 55 elevated homocysteine 55 serum parathyroid hormone 55 angina chest 55 Uncontrolled hypertension 55 SLNB 55 inflammatory biomarkers 55 arterial inflammation 55 cardiac tamponade 55 hepatocellular carcinoma 55 CMV infection 55 nonfatal MI 55 arterial thrombosis 55 Endothelial dysfunction 55 recurrent venous thromboembolism 55 coronary vessels 55 bridging fibrosis 55 calcified plaque 55 neurocognitive deficits 55 artery blockages 55 dysglycemia 55 elevated LDL cholesterol 55 familial hypercholesterolemia 55 plasminogen activators 55 carotid plaques 55 gastric adenocarcinoma 55 myocyte 55 valvular heart disease 55 serum triglycerides 55 nonfasting triglycerides 55 nonfasting triglyceride levels 55 cerebral vascular 55 mitochondrial toxicity 55 postoperative complications 55 lumbar disk herniation 55 Oxidative stress 55 cirrhotic patients 55 cranial irradiation 55 neurological abnormalities 55 Genetic predisposition 55 cardiac troponin 55 intestinal permeability 55 cerebral vascular disease 55 myocardial infarction MI 55 undergoing CABG 55 antiphospholipid antibodies 55 squamous cell lung cancer 55 lipohypertrophy 55 malignant neoplasm 55 vascular reactivity 55 hemodilution 55 hepatorenal syndrome 55 postoperative mortality 55 cerebrovascular accidents 55 endothelial dysfunction 54 dysrhythmias 54 neurologic complications 54 contrast induced nephropathy 54 pressure natriuresis 54 atherosclerotic lesion 54 intima media thickness 54 factor PlGF 54 nonvertebral fractures 54 post thrombotic syndrome 54 soluble CD# ligand 54 interstitial lung disease 54 extracranial 54 monoclonal gammopathy 54 diabetic nephropathy 54 pulmonary inflammation 54 gastric varices 54 lipid concentrations 54 systemic inflammation 54 metabolic disturbances 54 overt nephropathy 54 chronic pancreatitis 54 deep venous thrombosis 54 serum calcium 54 intracranial atherosclerosis 54 cerebral ischemia 54 Pulmonary hypertension 54 beta blocker therapy 54 VEGF expression 54 isolated systolic hypertension 54 idiopathic pulmonary 54 pulmonary emphysema 54 Ascherio 54 PROactive study 54 LAGB 54 chorioamnionitis 54 clinically insignificant 54 immunosuppressive therapies 54 acute coronary 54 HIV HCV coinfected 54 cardiomegaly 54 cTnT 54 proteinuria 54 vascular calcification 54 Prehypertension 54 Cognitive impairment 54 Proteinuria 54 serum PSA 54 thrombophilia 54 morphometric vertebral fractures 54 angiographically 54 proliferative diabetic retinopathy 54 impaired endothelial 54 T1DM 54 nonischemic cardiomyopathy 54 myeloperoxidase 54 uterine tumors 54 Torsades de Pointes 54 interstitial lung abnormalities 54 acute myelogenous leukemia AML 54 vasospasm 54 serum cholesterol 54 insulin resistance 54 liver fibrosis 54 ventricular tachycardia VT 54 visceral adiposity 54 listed hypertensive cardiovascular 54 left ventricular diastolic 54 rFVIIa 54 fibrin deposition 54 myocardial infarctions MIs 54 macrovascular 54 PLX STROKE targeting 54 prognostic marker 54 elevated CRP 54 thrombocytopenic 54 mitral stenosis 54 hsCRP 54 aminotransferases 54 acute myocardial infarction AMI 54 distal colon cancer 54 lymphoproliferative disorder 54 insulin resistance syndrome 54 nodal metastasis 54 inducible nitric oxide synthase 54 infective endocarditis 54 colorectal carcinoma 54 thymoma 54 hypertensive rats 54 AA Amyloidosis 54 atheroma volume 54 pleural effusions 54 restenosis reblockage 54 thrombus formation 54 CHD CVD 54 allogeneic HSCT 54 prostate carcinogenesis 54 PSADT 54 vertebral artery dissection 54 progressive dyspnea 54 obstructive coronary 54 hypercalcaemia 54 IPAH 54 hematopoietic cancers 54 atherosclerotic progression 54 APOL1 54 liver histology 54 CYP #A# 54 atherosclerosis hardening 54 INTERHEART study 54 APOE e4 54 gastric lymphoma 54 perioperative morbidity 54 KIF6 gene variant 54 neovascularization 54 comorbidity 54 hyperalgesia 54 acetabular dysplasia 54 ischemic stroke 54 infarct 54 severe hyperbilirubinemia 54 interstitial fibrosis 54 thrombo embolic 54 acute myocarditis 54 serum urate levels 54 glycated hemoglobin levels 54 nonfatal stroke 54 primary hyperparathyroidism 54 serum phosphate 54 malignant neoplasms 54 aortic rupture 54 intracerebral hemorrhage ICH 54 advanced adenoma 54 brain lesions 54 arteriography 54 premalignant 54 proinflammatory cytokines 54 left ventricular systolic 54 carotid arterial 54 FFR measurements 54 plasma lipid 54 carcinoid tumor 53 arteriosclerotic 53 granulomatous 53 coagulopathy 53 ABCB1 53 recurrent ischemia 53 rate variability HRV 53 tumor lysis syndrome 53 thyroid carcinoma 53 atherosclerotic plaques 53 uveal melanoma 53 haemorrhagic stroke 53 MALT lymphoma 53 CHD mortality 53 Vitamin D insufficiency 53 Fatty liver 53 patients undergoing CABG 53 diastolic hypertension 53 cardiogenic shock 53 angina pectoris 53 recurrent VTE 53 graft dysfunction 53 necrotizing 53 cystatin C 53 arterial thromboembolic events 53 Adiposity 53 airflow limitation 53 hyperkalemia 53 demyelination 53 microvascular 53 carotid bruit 53 Alzheimer pathology 53 cirrhotic liver 53 Ischemic heart 53 hypertrophy 53 onset atrial fibrillation 53 prostate carcinoma 53 cerebral embolism 53 catheter angiography 53 recurrent glioblastoma multiforme 53 kidney dysfunction 53 activated microglia 53 Venous thromboembolism 53 neurocognitive impairment 53 lymph node metastasis 53 Coronary artery disease 53 dexrazoxane 53 hemorrhagic strokes 53 pathophysiologic 53 hypoplasia 53 Cardiac hypertrophy 53 graft occlusion 53 colorectal neoplasia 53 colorectal cancer CRC 53 myocardial infarct 53 autocrine 53 adrenal insufficiency 53 antiphospholipid syndrome 53 cytopenias 53 imatinib resistance 53 distal embolization 53 radiculopathy 53 cardiac repolarization 53 sustained ventricular tachycardia 53 testicular tumors 53 pulmonary resection 53 nasopharyngeal carcinoma 53 fatty acid oxidation 53 cardio vascular disease 53 impaired cognition 53 metaplasia 53 acute myocardial infarctions 53 ischemic colitis 53 myeloproliferative neoplasms 53 natriuresis 53 clinicopathological features 53 CRBSI 53 hypovitaminosis D 53 Multivariate analyzes 53 ischemic heart 53 OPCAB 53 primary aldosteronism 53 familial adenomatous polyposis FAP 53 hyperacute 53 NYHA Class II 53 cardioembolic stroke 53 pulmonary emboli 53 atrial tachyarrhythmias 53 Idiopathic pulmonary fibrosis 53 interstitial pneumonitis 53 arteries atherosclerosis 53 fibrosis progression 53 Arrhythmogenic Right Ventricular Cardiomyopathy 53 urine NGAL 53 nontraumatic 53 lupus scleroderma 53 atypical hyperplasia 53 atherothrombotic events 53 Polycythemia vera 53 pericardial effusion 53 heterotopic ossification 53 familial pancreatic cancer 53 gene polymorphisms 53 lactate dehydrogenase LDH 53 cardiomyopathies 53 postmenopausal breast cancer 53 G6PD deficiency 53 thrombolytic agents 53 hyperplasia 53 hereditary predisposition 53 vaso occlusive crisis 53 paraganglioma 53 neuroblastomas 53 Sleep disordered breathing 53 atypical ductal hyperplasia 53 serum creatinine levels 53 acute leukemias 53 RBP4 53 atrial arrhythmias 53 cardioprotection 53 haematopoietic 53 alanine aminotransferase ALT 53 adenocarcinomas 53 renal scarring 53 angiotensin converting enzyme inhibitors 53 renal artery stenosis 53 coronary heart 53 anti fibrotic 53 nephropathy 53 angiotensin receptor blockers 53 chromosomal instability 53 microangiopathy 53 depressive symptomatology 53 serum estradiol 53 NYHA functional class 53 diabetes mellitus DM 53 cerebrovascular events 53 non valvular atrial 53 intracranial haemorrhage 53 intracoronary 53 bacteriuria 53 smoldering myeloma 53 Helicobacter infection 53 esophageal squamous cell carcinoma 53 liver scarring 53 intracranial stenosis 53 thromboembolic disease 53 atrophic gastritis 53 Clogged arteries 53 spine fractures 53 IL 1ß 53 gastric cardia 53 plaque rupture 53 nonvertebral fracture 53 plasma triglycerides 53 Subarachnoid hemorrhage 53 myocardial dysfunction 53 fibrogenesis 53 serum uric acid 53 H. pylori infection 53 biochemical abnormalities 53 metabolic abnormality 53 prednisone prednisolone 53 Pulmonary embolism 53 cardio metabolic 53 RBP4 levels 53 colon perforation 53 untreated OSA 53 calcified plaques 53 GPC5 53 antigen PSA 53 Mitral valve 53 Observational studies 53 intraventricular hemorrhage 53 congenital malformations 53 fasting triglycerides 53 IGFD 53 renal allograft 53 pulmonary metastasis 53 Diabetic neuropathy 53 ischemic vascular 53 multivariable analyzes 53 deep venous thromboses 52 folate deficiency 52 bicuspid aortic valves 52 decompensated cirrhosis 52 chronic renal insufficiency 52 mammographic density 52 cervical neoplasia 52 anoxic encephalopathy 52 ventricular dilatation 52 cardiogenic pulmonary edema 52 lipogenesis 52 kidney urologic 52 paroxysmal atrial fibrillation 52 poorer prognosis 52 Hypertrophic cardiomyopathy 52 conventional angiography 52 venous thromboembolism 52 fasting insulin 52 nonfatal myocardial infarction MI 52 elevated uric acid 52 acute cholecystitis 52 acute myocardial infarction 52 GRK5 52 neurodevelopmental impairment 52 osteolytic 52 skeletal metastases 52 intermittent hypoxia 52 hyperplastic polyps 52 osteopontin 52 juvenile idiopathic arthritis 52 autoimmune thyroid 52 IGFBP 3 52 tissue fibrosis 52 arthropathy 52 Idiopathic 52 postoperative complication 52 arterial blockage 52 proteoglycan 52 white matter hyperintensities 52 Cardiopulmonary bypass 52 macroalbuminuria 52 dyslipidemia hypertension 52 giant cell arteritis 52 fibrinolysis 52 adiponectin 52 periodontal infection 52 ALB # 52 Eisenmenger syndrome 52 Aprotinin 52 chemoresistance 52 adenomatous 52 nonadherence 52 Chronic pancreatitis 52 Non Alcoholic Steatohepatitis 52 neonatal morbidity 52 oxidized phospholipids 52 invasive fungal infection 52 C. pneumoniae 52 tachyarrhythmias 52 bladder cancers 52 Elevated CRP 52 eplerenone 52 severe mitral regurgitation 52 Computerized tomography 52 prognostic significance 52 infantile hemangioma 52 pulmonary thromboembolism 52 recurrent miscarriage 52 fatal myocardial infarction 52 paraneoplastic 52 unstable angina UA 52 paragangliomas 52 HeFH 52 hypertension 52 functional mitral regurgitation 52 Endothelial function 52 elevated serum creatinine 52 sudden cardiac death 52 multisystem organ failure 52 diastolic heart 52 basilar 52 bypass grafting 52 necrotic core 52 gross hematuria 52 ovarian carcinoma 52 acute coronary syndromes ACS 52 paroxysmal AF 52 hypovolemia 52 allograft rejection 52 lipid lowering therapy 52 hemodynamic instability 52 familial adenomatous polyposis 52 Multivariate analysis 52 papillary renal cell carcinoma 52 Alagille syndrome 52 elevated bilirubin 52 fatty infiltration 52 primary biliary cirrhosis 52 definite stent thrombosis 52 dyssynchrony 52 renal toxicity 52 contralateral breast cancer 52 Legg Calvé Perthes disease 52 serum triglyceride levels 52 venous reflux 52 carotid artery intima media 52 Hypotension 52 amyloid deposition 52 ECG abnormalities 52 fatty liver disease 52 reperfusion injury 52 sinus bradycardia 52 arterial stenosis 52 Gastric cancer 52 steatosis 52 LV ejection fraction 52 juvenile idiopathic arthritis JIA 52 lymph node metastases 52 stratifying patients 52 chronic GVHD 52 invasive ductal 52 pulmonary capillary wedge 52 KIF6 carriers 52 torsades de pointes 52 V Leiden 52 obesity insulin resistance 52 recurrent atrial fibrillation 52 SNHL 52 c myc gene 52 macrovascular complications 52 cardiotoxicity 52 Atherosclerotic 52 carotid artery stenting CAS 52 Inosine 52 Cardiogenic shock 52 ß blockers 52 syndrome ARDS 52 clusterin 52 cardiovascular ischemic 52 clot formation 52 Hashimoto thyroiditis 52 hyperparathyroidism 52 esophageal varices 52 intravenous bisphosphonates 52 comorbidities 52 multivessel disease 52 Angiotensin converting enzyme 52 Sezary syndrome 52 primary sclerosing cholangitis 52 epithelial tumors 52 VT VF 52 glomerular 52 interstitial pneumonia 52 atherosclerosis thickening 52 sickling 52 esophagitis 52 metabolic dysfunction 52 reflux esophagitis 52 vitamin D inadequacy 52 Hypertensive Cardiovascular Disease 52 neointimal 52 CTEPH 52 neuritic 52 neurological complications 52 cardiac myocytes 52 Carotid artery 52 venous thromboembolic disease 52 troponin T 52 inotropic 52 extrahepatic 52 parkinsonism 52 chronic thromboembolic pulmonary 52 collagen degradation 52 nodular melanoma 52 prognostic variables 52 coinfection 52 neurologic symptoms 52 cobiprostone 52 Stent thrombosis 52 metastatic malignant 52 VADT 52 coronary insufficiency 52 nesiritide 52 hyperprolactinemia 52 TGF ß1 52 chronic prostatitis 52 ischemic 52 fasting glucose levels 52 HF hospitalization 52 leukoencephalopathy 52 intensive statin therapy 52 VTEs 52 syndrome OSAS 52 colorectal neoplasms 52 Elevated serum 52 Langerhans cell histiocytosis 52 surgical revascularization 52 symptomatic aortic stenosis 52 adiposity 52 mitral regurgitation MR 52 varices 52 lipid lowering therapies 52 nonfatal myocardial infarction 52 macrovascular disease 52 morbidity mortality 52 thiazide diuretic 52 ischemia 52 disk herniation 52 mtDNA mutations 52 psychiatric comorbidity 52 deferiprone 52 plasma homocysteine 52 unfavorable prognostic 52 aldosterone hormone 52 adenoma 52 opiate intoxication 52 serum selenium 52 angiotensin receptor blockers ARBs 52 thyrotoxicosis 52 primary pulmonary hypertension 52 serum calcium levels 52 afterload 52 precancerous tumors 52 stenosis 52 c reactive protein 52 mL/min/#.# m 2 52 neovascularisation 52 sinus node dysfunction 52 LDL cholesterol lowering 52 intravenous diuretics 52 NF kappaB activation 52 HER2 expression 52 bronchopulmonary dysplasia BPD 52 cardiac conduction 52 GH deficiency 52 dermatomyositis 52 atherosclerosis regression 52 enteroviral infection 52 liver metastasis 52 EXJADE 52 acute hepatic 52 Intussusception 52 deep vein thromboses 52 lumbosacral 52 Coronary artery calcium 52 ductal adenocarcinoma 52 carcinoid tumors 52 ApoA1 52 serous ovarian cancer 52 ADAMTS# 52 intracerebral 52 NATRECOR ® 52 pancreatic prostate 52 allogeneic bone marrow 52 β amyloid 52 Thrombotic thromboembolic complications 52 biliary tree 52 prostate TURP 52 neoplastic lesions 52 PCa 52 polyp recurrence 52 rs# [002] 52 Myocarditis 52 seizures comas 52 SCr 52 recanalization 52 varus deformity 51 intraoperative complications 51 vitamin D insufficiency 51 elevated ALT 51 acute renal failure 51 thrombotic 51 Adjuvant chemotherapy 51 viable myocardium 51 Peripheral arterial disease 51 HbF 51 antithrombotic therapy 51 intrahepatic 51 perfusion defects 51 histologically 51 hypercholesterolemia 51 thickness CIMT 51 fatal IHD 51 psychiatric comorbidities 51 hyperplastic 51 fatty plaque buildup 51 osteoid 51 knee osteoarthritis OA 51 HDL LDL ratio 51 oncomodulin 51 idiopathic cardiomyopathy 51 Renal dysfunction 51 Hip fracture 51 Chlamydia pneumoniae 51 troponins 51 fibrotic disease 51 atherosclerotic cardiovascular 51 INCB# [003] 51 neoplasm 51 hepatic fibrosis 51 serum lipids 51 bullous 51 airflow obstruction 51 latent celiac disease 51 left ventricular LV 51 Physical inactivity 51 erythropoietic 51 hypercalcemia 51 lymphatic cancers 51 protein excretion 51 antihypertensive therapy 51 cardiac toxicity 51 Acetaminophen overdose 51 revascularisation 51 multivariate adjustment 51 aortic stenosis 51 hematologic toxicity 51 Severe hypoglycemia 51 mixed hyperlipidemia 51 postmenopausal hormone replacement 51 papillary carcinoma 51 Renal impairment 51 thrombogenic 51 alcoholic liver 51 E selectin 51 supraventricular arrhythmias 51 gouty arthritis 51 loop diuretics 51 LRP5 51 hyperbilirubinemia 51 Papillary 51 malperfusion 51 tHcy 51 airway constriction 51 co morbidities 51 ductal cancer 51 antiplatelet medication 51 NMIBC 51 neoplastic 51 mucociliary clearance 51 abnormal uterine bleeding 51 ANCA associated 51 underactive thyroid gland 51 coagulation abnormalities 51 familial hypercholesterolemia FH 51 chlamydial infection 51 fibrotic 51 antithrombotic agents 51 artery calcification 51 malignant lymphoma 51 myocarditis 51 geographic atrophy 51 peptide BNP 51 capillary leakage 51 neuroinflammation 51 precancerous cervical 51 acid suppressive medications 51 cutaneous melanoma 51 dentinal hypersensitivity 51 benign positional vertigo 51 inflammatory cytokine 51 steatohepatitis 51 coronary revascularization procedures 51 breast cancer metastasis 51 malarial anemia 51 sCJD 51 hypercholesterolaemia 51 multivariate Cox